Member Info for rhubarbmk2

OK - I'm not a fan of this generally in AIM, and may spoil others' fun in documenting this (sorry), but if you're a chartist, what do you make of this:

20th August - Peak 1 - 24p.
10th September - Neckline 1 - 23 p.
17th September - Peak 2 - 30p.
23rd September - Neckline 2 - 28p.
30th September - Peak 3 - 42p.
7th October - Neckline 3?

Look at the chart - I wish Iceman could crayon on them for illustration. It's double-bottom tasctic. The bullish movements are compressing with time, mind.

If Peak 3 hadn't been triggered by the QandA, and if we mere humans left it to algorithmic forecasting, I reckon we'd be Peak 4 around the 14th October, at 66p. :-)

Question is, have we reached Neckline 3, and will you pull out for the weekend? In my case, S0d that, but I wonder how many are blind trading, based on this.

I've said it before, NH (and glad to see you back), but to was the masonic hand movements that gave it away for me; signalling to his mates at the lodge to load up. :-)

Suzy is growing in both stature and confidence. I'll love it when she goes full bull.

You just couldn't be invested, IMO, at a more exciting time.

Alright - that's overly kind of you all, but you're all here through your own research, and so you have to give yourselves full credit, and yourselves only, when things go well.

TH makes a good point. The peers sometimes have a candidate in the clinic and maybe 1 or 2 (often with multiple clinical targets) at the preclinical stage - 150-300MCap.

Suzy is looking to bring in 3+ preclinicals a year - that's a tremendous aim, and should ensure that we are well front-loaded, going forward.

If you look closely at peers too, their candidates are often co-developed (as 201). Some are wholly owned, but many are in conjunction with others. Many have their own wet labs; some better than others, but they still only bring one or so in, every couple of years, sometimes less.

All-in-all, I like the reward potential here very much. If you can get just one new preclinical TA of potential in, per year, that's a really strong pipeline for growth.

I have a view that Suzy will be marketing one valuable TA, at IND stage, per 1-1.5 years. That is fairly unprecedented work. She's definitely setting a very high bar, and I think the team can do it.

TY good Doctor. I think you should join us, as Minister of pr!cck detection, and comedic ****t deflection.

The best thing Cenkos could do, would be to inject some gel-haired exuberance into the proceedings, by TR-1'ing themselves.

Come on; support the terrific CEO, and show SH's that you're not just in it for some cheap shares.

Two clinical phase candidates, and one clinic-ready candidate, for a MCap of a new-entry IPO - with - NOTHING.

Come at me shoeshine boys.

Subtle as dysentery is the phrase you're looking for OB. :-)

Good man.

Are you back in tomorrow then, old fruit? If so, I might join you in a top up myself.

As my old teacher once said, on encountering some discarded small change coins on the floor, "if they're daft enough to drop them, I'm daft enough to pick them up".

Come on Bonkers - I'm still waiting for you to tell me which "non-commercial" clinical trials you've run as a Principal Investigator.

It'll be in the public domain, so don't hold back the details. I'll understand them, so fire away...

We may be in pump and dump territory, but at least there's a pump to look forward to. Unlike poor SYME holders, eh, where it's just an endless, unrelenting, colonic irrigation - ouch!

Although I can see from that outfit, why you and Captain Jen have been frequenting this board to spread the misery. Must be painful for you both.

See - I can do de-ramping too - easiest job in the world - it doesn't make you feel better about yourself though, does it?

If it slips down to high teens again, I'll double my holding.

I think that there's a lot of spewing going on here.

The fact remains that there is going to be a deal for 201. Getting in a lather over the upfront payment, or TA, to me, is missing the point.

As an investor or trader, you have to ask yourself whether you want to make money. There's a better heads-up here, than in any 100M+ MCap floated biotech, that the SP will materially rise, at some stage, over the next few weeks. The fact that VAL is water-tight gives me slight pleasure in seeing who can guess the trading ranges, and those who want to make a few TA/prediction-related sheets in the interim. Different strokes for different folks. Do you risk being "out", or are you going to avoid a stomach ulcer and stay "in". Everyone seems a little nervous. Me; I'm relaxed.

Hopefully by December, the SP will have changed. We should have a proven strategy and some revenue. But with that, I can't say that I'll be disappointed that it is no longer purely a ST traders share.

Ultimately, the SP should reflect 1. Confidence around the name of the partner, and justification/demonstration of the strategy (can't be underestimated); 2. A percentage of any total package; experience tells me 40%, but this is VAL, so you ever know for sure; 3. The upfront payment.

IME, I think that the above will be the order of priority for bigger LT investors, proper, and, most notably, IIs.

I've never barrier traded, but don't castigate those who do. But what I would say is that there are people on here, who are purposefully scaring new and less experienced investors with hokus pokus, because they are trying to buy a lot of shares at the lowest possible value. They need to take a good long hard look at themselves.

I don't want to dish out any advice, but for those in the former category; ask yourselves if you want to make an informed investment decision, based around what you’ve been told by the BOD themselves; please don't panic about the very short-term movements.

Many newer investors have come to VAL and thoroughly researched, for themselves, the risk:benefit ratios. They've gotten to know the IP, the management, and taken a position. The last thing they need is a bunch of d!cck*eads, who again, should know better, playing their own agenda. It's shameful. As far as I’m concerned, come the deal, you can shove your candlesticks where the sun no longer shines.

No; it didn't cross my mind that you were PP. But I'd be disappointed myself if I'd have taken the warrants at face value, and not challenged, so just thought I'd tell you I did.

Paperprofits. As with any shareholder, yes; I took the BOD to task over the warrants. And as with any other shareholder, I was given non-sensitive, but comprehensive, justification.

Mark in particular, I gave a proper grilling to. That lad is smashing. Takes it on the chin, then comes back robustly, with a few swings of his own, giving excellent representation of the Company. I like that very much. You get nowhere sucking up to the SH's, and he thoroughly impressed me with his responses and arguments.

The QandA was absolutely first class.

From all these end-points, I know that the Company are very confidently growing a 9 figure MCap, and I think they will achieve this, perhaps more easily than they even think themselves.

It's a complete no brainer for me at this juncture to be invested at this level.

Bet Big Kev drives a Bugatti.

OK I'll come clean; I use it for top soil, aggregate and sheep feed. No one ever thinks I'm a scientist though, so that's a bonus. Hate to be tarred by that geek brush.

The babes are also inflatable. But if you drive fast enough, they look real :-)

Now why would I have one of those. Strategy has evolved, and continues to do so; and so have my thoughts about the investment. Firm exit strategies IME are something you have to justify not undertaking, when you change your mind :-)

*can't.